Radiotherapy, physics-based modeling, resource competition, positive selection in healthy tissue, and more
, , and
Personalized radiotherapy, causality in cancer, nano-particle drug delivery, antifragility, drug resistance, hierarchical tissue organization
, , and
Adaptive therapy, translational modeling, immune-spatial patterns, model-informed drug development, fitness landscapes
, , and
Organoid environmental effects, classic growth models in humans, adaptive therapy, model-informed drug development, tumor-immune interactions
, , and
Collateral sensitivity, optimal control, persistent homology, non-genetic inheritance, uncertainty quantification, and more...
, , and
Radiation-immune dynamics, plasticity, cultivating computational biology, immunotherapy resistance hallmarks, metabolic scaling theory
, , and
Website re-design, intratumoral heterogeneity, spatial immunophenotypes, CAR T-cell, coexistence phenotypes, and more
, , and
Drug interactions, MRI tumor forecasting, neutral evolution, collateral sensitivity, game theory, and immune-tumor coevolution.
, , and
Reversible resistance, non-darwinian evolution, drug synergy, tumor heterogeneity, traveling wave trade-offs
and
Organoid shape dynamics, modeling survival, plasticity, cooperation/competition, cell communication, spatial interactions, and more
and
Voronoi tessalating public goods games, multi-tasking cancer evolution, agent-based vs differential eqns, Darwinian evolution, game theory, and network…
and
Contact inhibition, EMT-immune dynamics, multistep growth models, Allee effect, mutation frequency, anti-angiogenic therapy
and